Boston University Libraries OpenBU
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    •   OpenBU
    • BU Open Access Articles
    • BU Open Access Articles
    • View Item
    •   OpenBU
    • BU Open Access Articles
    • BU Open Access Articles
    • View Item

    Trial-based cognitive therapy: efficacy of a new CBT approach for treating social anxiety disorder with comorbid depression

    Thumbnail
    Date Issued
    2018-09-01
    Publisher Version
    10.1007/s41811-018-0028-7
    Author(s)
    Caetano, Katia A. S.
    Depreeuw, Barbara
    Papenfuss, Inka
    Curtiss, Joshua
    Langwerden, Robbert J.
    Hofmann, Stefan G.
    Neufeld, Carmem B.
    Share to FacebookShare to TwitterShare by Email
    Export Citation
    Download to BibTex
    Download to EndNote/RefMan (RIS)
    Metadata
    Show full item record
    Permanent Link
    https://hdl.handle.net/2144/33620
    Version
    Accepted manuscript
    Citation (published version)
    Katia AS Caetano, Barbara Depreeuw, Inka Papenfuss, Joshua Curtiss, Robbert J Langwerden, Stefan G Hofmann, Carmem B Neufeld. 2018. "Trial-Based Cognitive Therapy: Efficacy of a New CBT Approach for Treating Social Anxiety Disorder with Comorbid Depression." INTERNATIONAL JOURNAL OF COGNITIVE THERAPY, Volume 11, Issue 3, pp. 325 - 342 (18). https://doi.org/10.1007/s41811-018-0028-7
    Abstract
    The present study aims to evaluate the efficacy of Trial-Based Cognitive Therapy (TBCT), a new cognitive-behavioral therapy approach, for generalized social anxiety disorder (GSAD) in a population with high rates of comorbid disorders, especially depression. This two-arm randomized clinical trial included 39 adults (TBCT = 18; waitlist group = 21) diagnosed with GSAD. The TBCT group received 16 weekly sessions of individual TBCT. Symptom severity was assessed at pre- and post-treatment. Participants in the TBCT group showed reduction in social anxiety, social avoidance, and depression, all associated with a large effect size. No differences between pre- and post-treatment scores were observed in the waitlist condition. Results also showed that comorbidity significantly moderated treatment efficacy. Patients with comorbid conditions showed greater reductions in social anxiety symptoms across treatment than those with SAD only. In summary, TBCT was effective in reducing social anxiety and depressive symptoms, particularly for patients with comorbidity.
    Description
    This is a post-peer-review, pre-copyedit version of an article published in International Journal of Cognitive Therapy. The final authenticated version is available online at: http://dx.doi.org/10.1007/s41811-018-0028-7
    Collections
    • CAS: Psychological and Brain Sciences: Scholarly Papers [232]
    • BU Open Access Articles [3664]


    Boston University
    Contact Us | Send Feedback | Help
     

     

    Browse

    All of OpenBUCommunities & CollectionsIssue DateAuthorsTitlesSubjectsThis CollectionIssue DateAuthorsTitlesSubjects

    Deposit Materials

    LoginNon-BU Registration

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Boston University
    Contact Us | Send Feedback | Help